Joseph Palumbo
Chief Tech/Sci/R&D Officer at BIOVIE INC.
Net worth: 3 930 $ as of 2024-03-30
Profile
Joseph M.
Palumbo is currently the Director at Hydreight Technologies, Inc. and the Chief Medical Officer at BioVie, Inc. He previously worked as the Head-Global & Franchise Medical at Johnson & Johnson, Vice President-US Medical Science at Mitsubishi Tanabe Pharma Corp., and as the Chief Medical Officer & Vice President at Zynerba Pharmaceuticals, Inc. Palumbo holds an undergraduate degree from the University of Pennsylvania Graduate School of Education and a doctorate from George Washington University School of Medicine & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVIE INC. CLASS A
0.01% | 2023-08-08 | 7,430 ( 0.01% ) | 3 930 $ | 2024-03-30 |
Joseph Palumbo active positions
| Companies | Position | Start |
|---|---|---|
| BIOVIE INC. | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| HYDREIGHT TECHNOLOGIES INC. | Director/Board Member | 2022-11-24 |
Former positions of Joseph Palumbo
| Companies | Position | End |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-09-30 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Training of Joseph Palumbo
| University of Pennsylvania Graduate School of Education | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| BIOVIE INC. | Health Technology |
| HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
| Private companies | 1 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Stock Market
- Insiders
- Joseph Palumbo
